IDEC  has joined forces with our Validant Group partners to reposition as one global regulatory brand: ELIQUENT Life Sciences.  The fusion of five global regulatory consultancies, ELIQUENT Life Sciences is built on the foundation of five global life science consultancies: Validant, Greenleaf Health, DataRevive, Oriel Stat-A-Matrix, and IDEC.

ELIQUENT Life Sciences creates an unprecedented assembly of regulatory leaders, industry experts, and technical specialists - brought together to bridge the spectrum of regulatory challenges across the product lifecycle. The collective capabilities of the united ELIQUENT team enable a comprehensive approach that delivers integrated solutions to support pharmaceutical, biotechnology, medical device, and combination product companies navigating the complex regulatory landscape.

From thought to finish, concept to commerce, and strategy to execution— ELIQUENT Life Sciences is the singular regulatory resource that clients around the world trust. 

LEARN MORE about our strategic repositioning and integrated service offerings at eliquent.com


Recently, we have created GPTs, “Japan Regulatory Insight,” that allow Q&A about newly issued regulatory notifications in Japan regarding the Japanese Phase 1 waiver and orphan drug designation, which have attracted much attention.

If you are a ChatGPT Plus subscriber, please click the link below to use the GPTs "Japan Regulatory Insight."

https://chat.openai.com/g/g-D5L83iRSi-japan-regulatory-insight
 
If you would like more detailed advice on your project than GPTs's general advice, please get in touch with IDEC!

Life Sciences

Medical Devices

Pharmaceutical

IDEC Inc

IDEC Inc's headquarters in Shinjuku, Japan

Description

People (1)

Masayoshi Takezawa

Jobs